Investing.com -- Johnson & Johnson (NYSE:JNJ) reported second-quarter results that exceeded Wall Street expectations, though shares are down around 1% premarket on Wednesday.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
By Michael Erman July 15 (Reuters) - Johnson & Johnson beat Wall Street estimates for second-quarter sales and profit on Wednesday, as strong growth from immunology drug Tremfya and cancer blockbuster
Eight thousand dollars a month is the kind of retirement income target that looks simple until the yield math starts moving underneath it. It translates to $96,000 a year, but the portfolio needed to produce that income can vary by well over $1 million depending on whether the investor accepts a 3.5% yield, a 6% ... What It Takes to Earn $8,000 a Month From Dividends Without Chasing Yield
Stocks looked set to rise again on Wednesday, building on gains from the previous session that were powered by a solid start to the second-quarter earnings season and cooler-than-expected inflation data. Nasdaq 100 futures added 0.4%. Dow Jones Industrial Average futures rose 81 points, or 0.2%.
↗️ PayPal Holdings (PYPL): Shares of the digital-payments company surged more than 15% in premarket trading following a Reuters report that payments processor Stripe and private-equity firm Advent offered to buy it for more than $53 billion.
Today Earnings: Johnson & Johnson, Morgan Stanley, BlackRock, PNC Financial Services, Conagra, Cintas, United Airlines, Bank of New York Mellon, Elevance Health, J.B. Hunt, ASML Economic data: Producer-price index data for June, Empire State manufacturing survey, EIA weekly petroleum status report, Fed beige book.
Here is a way to get paid a meaningful income now on your Intuitive Surgical shares, cash you keep no matter what, in exchange for capping your gains at a price above today's.
Johnson and Johnson just raised its full-year outlook toward a historic $100 billion revenue target, yet the stock still trades well below where our model says it should be. The real question is whether the pipeline can outrun the headwinds closing in fast.
A $1.4 million nest egg is far above the typical U.S. retirement account balance, but the check it writes each month depends entirely on how the assets are arranged. At a 3.5% yield, the portfolio produces $49,000 a year. At a 10% yield, it produces $140,000. The difference looks simple on a spreadsheet, but it ... A $1.4 Million Portfolio That Delivers Reliable Income Through Bull and Bear Markets
PFE's oncology business is in focus ahead of Q2 results as growth from key cancer drugs, biosimilars and pipeline updates may offset declines in older therapies.
Johnson & Johnson stock has returned 77.8% over the past five years and now sits at a point where a Discounted Cash Flow (DCF) intrinsic value estimate suggests meaningful upside while the broader valuation checks look much less generous. A 77.8% five year return sets the context for assessing whether today’s price still leaves enough potential reward for the risk involved. Progress in oncology and autoimmune drugs can support long term cash flow expectations, while ongoing talc related...
San Francisco makes passive income math unforgiving. SmartAsset’s 2026 comfort-salary study estimates that a single adult needs about $134,950 in pretax income to live comfortably in the city, among the highest figures in the country. Turning that paycheck into dividend income is not just a yield exercise. The yield an investor reaches for changes both ... A Dividend Portfolio That Can Cover the Cost of Living in San Francisco
JNJ's 25% year-to-date surge and recent FDA approval fuel interest in healthcare ETFs with diversified sector exposure.
This is a product-cycle year for Intuitive Surgical. The company's growth is fueled by hospitals and surgeons adopting its new da Vinci 5 and existing Ion robotic systems.
Set to go public via a reverse merger, Avere has licensed from a prolific Chinese drugmaker rights to a potential threat to medicines like Skyrizi and Icotyde.
The dividend looks secure. The share price is the harder call.
Investors are gearing up today for the start of a busy bank earnings season. They’ll also be closely watching the latest inflation data and appearances on Capitol Hill over two days by new Federal Reserve Chairman Kevin Warsh.
After hitting fresh all-time highs last week, investors are turning their attention to JNJ's Q2 report, which is scheduled for Wednesday, July 15, before the opening bell.
Social Security benefits come with inflation protection, but the tax formula attached to those benefits does not. For retirees with pensions, IRA withdrawals, taxable investment income, or municipal bond interest, a larger benefit can quietly mean a larger federal tax bill. The result is a tax rule from the 1980s that reaches more retirees every ... How Much of Your Social Security Will You Actually Keep After Taxes?
LQDA's Yutrepia posts a strong commercial debut, but sustaining growth will hinge on standing out in the crowded PAH market as competition intensifies.
Both Johnson and Johnson and Coca-Cola just beat earnings and both are pulling in capital fleeing tech, but only one of them earns its premium valuation in a world where pricing tailwinds can reverse overnight.
(Bloomberg) -- A federal appeals court revived lawsuits that claim Kenvue Inc. hid alleged risks that Tylenol could cause autism in children whose mothers took the over-the-counter pain medication while pregnant, a controversy that’s roiled the medical community.Most Read from BloombergLindsey Graham, Senate Hawk Turned Trump Ally, Dies at 71Trump Embraces Australian Retirement System Backed by Larry FinkHormuz Route Open Despite Iran Declaration, Maritime Group SaysOpenAI Engineer’s ‘LOL’ Momen
JNJ is set to report second-quarter results on July 15 as investors weigh strong growth drivers, new launches and patent headwinds shaping its long-term outlook.
An $80,000 salary is not the same as $80,000 of spendable income. Federal withholding, FICA taxes, state income taxes where they apply, and retirement contributions all reduce the number that actually reaches checking. For a single filer in a no-income-tax state, 2026 take-home pay on an $80,000 salary would be about $65,100 before retirement contributions, ... Think You’ll Live on $80,000 a Year? Here’s What Actually Lands in Your Checking Account